文献速递中毒与环境急症重症综合管理与镇静镇痛

美国重症监护病房物质相关入院流行病学

Epidemiology of Substance-Related Admissions to ICUs in the United States.
PubMed 文献 · Crit Care Med · 2025-07-30
一句话结论美国ICU入院中约六分之一存在物质相关诊断,酒精最常见且与住院死亡率升高相关(aOR 1.12)。

该多中心回顾性队列研究利用2016至2019年美国Premier医疗数据库,分析4,740,799例成人ICU入院,其中760,153例(16.0%)存在未缓解的物质相关障碍诊断。酒精相关占8.9%,阿片类占4.0%,兴奋剂占2.9%;阿片类相关入院中仅6.5%识别出海洛因使用。调整混杂因素后,酒精相关诊断(aOR 1.12)、女性(aOR 1.07)和非西班牙裔(aOR 1.08)与住院死亡率升高相关。物质相关ICU入院率随年龄、性别、种族和族裔不同而异,提示需针对成瘾相关诊断、治疗和二级预防进行资源分配。

要点

  • 4,740,799例ICU入院中760,153例(16.0%)有物质相关诊断,约每6例ICU入院中1例。
  • 酒精是最常见物质(占全部入院的8.9%),其次为阿片类(4.0%)和兴奋剂(2.9%)。
  • 阿片类相关ICU入院中仅6.5%识别出海洛因使用。
  • 调整协变量后,酒精相关诊断与住院死亡率升高相关(aOR 1.12,95%CI 1.06-1.19)。
  • 女性(aOR 1.07,95%CI 1.04-1.09)和非西班牙裔(aOR 1.08,95%CI 1.01-1.16)也与住院死亡率升高相关。

适用人群与场景

  • 美国ICU收治的成人患者,具有国际疾病分类第10版未缓解物质相关障碍诊断。
  • 数据来源于2016至2019年向Premier医疗数据库报告数据的美国ICU。

诊断标准与关键阈值

  • 物质相关诊断依据国际疾病分类第10版未缓解物质相关障碍编码确定。

研究设计与关键结果

  • 研究类型为多中心回顾性队列研究,样本量4,740,799例ICU入院,其中760,153例(16.0%,95%CI 16.00-16.07%)存在物质相关诊断。
  • 物质相关诊断患者平均年龄51.8岁,65.5%为男性,73.7%为白人,74.5%为非西班牙裔。
  • 酒精相关ICU入院占全部入院的8.9%(95%CI 8.87-8.92%),阿片类占4.0%(95%CI 3.97-4.01%),兴奋剂占2.9%(95%CI 2.91-2.94%)。
  • 多数物质相关ICU入院率在55-64岁患者以及自我认同为男性、非西班牙裔和「其他」种族(非白人、黑人、亚洲人)的患者中更高。
  • 白人与黑人两个最大种族组比较,白人患者阿片类相关ICU入院率更高,黑人患者兴奋剂相关ICU入院率更高。
  • 阿片类相关ICU入院中仅6.5%(95%CI 6.37-6.60%)识别出海洛因使用。
  • 多变量分析调整相关协变量后,酒精相关诊断(aOR 1.12,95%CI 1.06-1.19)、女性(aOR 1.07,95%CI 1.04-1.09)和非西班牙裔(aOR 1.08,95%CI 1.01-1.16)与住院死亡率升高相关。

证据类型、等级与局限

  • 证据类型:多中心回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,这些发现可能对将资源有效分配至成瘾相关诊断、治疗和ICU患者二级预防具有意义。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: To determine the prevalence, demographic characteristics, and predictors of in-hospital mortality for substance-related ICU admissions in the United States.

DESIGN: Multicenter, retrospective cohort study.

SETTING: U.S. ICUs reporting data to the nationally representative Premier Healthcare Database between 2016 and 2019.

PATIENTS: Adult ICU admissions with an International Classification of Diseases , 10th Revision diagnosis of a substance-related disorder not in remission.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Among 4,740,799 ICU admissions, a substance-related diagnosis was present in 760,153 (mean age 51.8 yr, 65.5% male, 73.7% White, 74.5% non-Hispanic), representing 16.0% (95% CI, 16.00-16.07%) of all ICU admissions or approximately one of every six ICU admissions. Alcohol was the most common substance associated with ICU admission (8.9% of all encounters; 95% CI, 8.87-8.92%), followed by opioids and stimulants (4.0%; 95% CI, 3.97-4.01% and 2.9%; 95% CI, 2.91-2.94%, respectively). Rates of nearly all substance-related ICU admissions were higher in patients 55-64 years old and in patients who identified as male, non-Hispanic, and "Other" race (not identified as White, Black, or Asian). In comparing White and Black patients, the two largest racial groups within our cohort, opioid-related ICU admission rates were higher in White patients while stimulant-related ICU admission rates were higher in Black patients. Only 6.5% (95% CI, 6.37-6.60%) of opioid-related ICU admissions identified heroin use. In multivariable analysis adjusting for relevant covariates, odds of in-hospital mortality following a substance-related ICU admission were higher for encounters that included alcohol-related diagnoses (adjusted odds ratio [aOR], 1.12; 95% CI, 1.06-1.19), female sex (aOR, 1.07; 95% CI, 1.04-1.09), and non-Hispanic ethnicity (aOR, 1.08; 95% CI, 1.01-1.16).

CONCLUSIONS: A substantial burden of substance-related diagnoses exists in patients admitted to ICUs. Alcohol use was most common and associated with increased hospital mortality relative to other substances. Rates of substance-related ICU admission differed by age, sex, race, and ethnicity. These findings may have implications for effective allocation of resources toward addiction-related diagnoses, treatment, and secondary prevention for ICU patients.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Hills-Dunlap K, McGrath M, Peterson R, et al. Epidemiology of Substance-Related Admissions to ICUs in the United States. Crit Care Med. 2025. PMID: 40736366. doi:10.1097/CCM.0000000000006803

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。